

US, China Agree to Continue Talks on Tariff Truce Extension
Jul 29, 2025
Joining the discussion are Oliver Crook, Bloomberg News Europe Correspondent, who shares insights on the latest U.S.-China tariff negotiations, and Brooke Sutherland, Boston Bureau Chief with a keen eye on industry trends. Kabir Nath, CEO of Compass Pathways, discusses the groundbreaking potential of synthetic psilocybin for treating depression. They dive into U.S.-China trade dynamics, the strategic interests at play, and the promising future of psychedelic therapy, highlighting both economic and mental health impacts.
AI Snips
Chapters
Transcript
Episode notes
Conditional Tariff Truce Extension
- The US-China tariff truce extension is contingent upon President Trump's final decision.
- Both sides exchanged concessions particularly on rare earths and tech, showing mutual leverage.
Unresolved Trade Topics Remain
- TikTok sale and fentanyl issues remain unresolved in trade talks.
- China's stance on sovereignty complicates secondary sanctions tied to Russian oil purchases.
China’s Negotiation Posture and Progress
- China wants to appear weak on concessions while allies appear to give the US more.
- Despite no deal today, negotiations were constructive with hope for future agreement.